Get the Stockscreener App
2.36
3.06%
0.07
Seer Inc stock is traded at $2.36, with a volume of 171.55K.
It is up +3.06% in the last 24 hours and up +2.16% over the past month.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.
See More
Previous Close:
$2.29
Open:
$2.33
24h Volume:
171.55K
Relative Volume:
0.77
Market Cap:
$139.16M
Revenue:
$14.86M
Net Income/Loss:
$-91.00M
P/E Ratio:
-1.6389
EPS:
-1.44
Net Cash Flow:
$-73.57M
1W Performance:
+3.06%
1M Performance:
+2.16%
6M Performance:
+31.11%
1Y Performance:
+46.58%
1-Day Range:
$2.325
$2.415
1-Week Range:
$2.26
$2.415
52-Week Range:
$1.51
$2.625
Seer Inc Stock (SEER) Company Profile
Name
Seer Inc
Sector
Industry
Phone
650-453-0000
Address
3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY
Compare SEER with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SEER
Seer Inc
|
2.36 | 139.16M | 14.86M | -91.00M | -73.57M | -1.44 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Seer Inc Stock (SEER) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-05-23 | Resumed | JP Morgan | Neutral |
| Jan-04-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Aug-11-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Dec-29-20 | Initiated | BofA Securities | Neutral |
| Dec-29-20 | Initiated | Cowen | Outperform |
| Dec-29-20 | Initiated | JP Morgan | Overweight |
| Dec-29-20 | Initiated | Morgan Stanley | Equal-Weight |
View All
Seer Inc Stock (SEER) Latest News
Seer, Inc. (NASDAQ:SEER) Shares Purchased by Geode Capital Management LLC - Defense World
Seer, Inc. (NASDAQ:SEER) Shares Purchased by Barclays PLC - Defense World
Jane Street Group LLC Sells 115,722 Shares of Seer, Inc. (NASDAQ:SEER) - Defense World
Seer to Present at the J.P. Morgan 43rd Annual Healthcare Conference - GlobeNewswire
Seer to Present at J.P. Morgan Healthcare Conference: Proteomics Pioneer Takes Center Stage - StockTitan
Spotlight On US Penny Stocks For January 2025 - Simply Wall St
Al Seer Marine Expands Fleet With Two New Tankers - MarineLink
XTX Topco Ltd Makes New Investment in Seer, Inc. (NASDAQ:SEER) - Defense World
Seer (NASDAQ:SEER) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
Charles Schwab Investment Management Inc. Sells 66,725 Shares of System1, Inc. (NYSE:SST) - Defense World
Seer, Inc. (NASDAQ:SEER) Shares Sold by Charles Schwab Investment Management Inc. - Defense World
Seer, Inc. (NASDAQ:SEER) Shares Sold by Fmr LLC - Defense World
Slate Grocery REIT USD (SGR-U-T) QuotePress Release - The Globe and Mail
SEER AND ECO TADWEER SHOWCASE SIGNIFICANT ACHIEVEMENTS IN THE KINGDOM OF SAUDI ARABIA WITH MULTIPLE BIOCHAR APPLICATIONS AND GROW STUDIES - The Manila Times
SEER AND ECO TADWEER SHOWCASE SIGNIFICANT ACHIEVEMENTS IN - GlobeNewswire
SEER Unveils Breakthrough 'Saudi Char' Technology for Green Riyadh Project, Revolutionizing Desert Soil Enhancement - StockTitan
SEER PARTNERS WITH DEVVSTREAM TO MONETIZE INSURED CARBON CREDITS ARISING OUT OF METHANE RENEWABLE ENERGY, CAPTURED OIL FIELD WELL EMISSIONS AND OTHER SEER PROJECTS - The Manila Times
SEER PARTNERS WITH DEVVSTREAM TO MONETIZE INSURED CARBON - GlobeNewswire
SEER PARTNERS WITH DEVVSTREAM TO MONETIZE INSURED CARBON CREDITS ARISING OUT OF METHANE RENEWABLE ENERGY, - EIN News
DevvStream Enters Biogas Market via Partnership with Methane Renewable Energy Leader - Newsfile
PrognomiQ, Inc. announced that it expects to receive $52.786374 million in funding - Marketscreener.com
Seer stock touches 52-week high at $2.54 amid market rally By Investing.com - Investing.com South Africa
Seer stock touches 52-week high at $2.54 amid market rally - Investing.com Canada
Seer Inc (SEER) Q2 2024 Earnings Call Highlights: Navigating Rev - GuruFocus.com
Seer Ranked Number 57 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™ - GlobeNewswire
Seer Achieves 2,440% Revenue Growth, Ranks 57th on Deloitte Fast 500™ | SEER Stock News - StockTitan
Seer, Inc. (SEER) Reports Q3 Loss, Tops Revenue Estimates - MSN
Seer Enters Into a Co-Marketing and Sales Agreement With Thermo Fisher Scientific - Technology Networks
Seer Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Seer stock soars to 52-week high, touches $2.3 amid growth - Investing.com India
Seer, Inc. (NASDAQ:SEER) Q3 2024 Earnings Call Transcript - Insider Monkey
Seer to Participate in Upcoming November Investor Conferences - GlobeNewswire
Seer (SEER) to Present at Two Major Healthcare Investment Conferences in November | SEER Stock News - StockTitan
Seer Inc (SEER) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic ... - Yahoo Finance
Seer Inc (SEER) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic ... By GuruFocus - Investing.com Canada
Seer Inc (SEER) Q3 2024 Earnings Call Highlights: Navigating Cha - GuruFocus.com
Seer, Inc. Reports Q3 2024 Financial Results - TipRanks
Seer Inc (SEER) Q3 2024 Earnings: Revenue Surpasses Estimates at $4.0 Million, GAAP EPS at -$0.35 - GuruFocus.com
Prognomiq raises $34M for early lung cancer detection test - BioWorld Online
SEERSeer, Inc. Latest Stock News & Market Updates - StockTitan
Seer Reports Third Quarter 2024 Financial Results - GlobeNewswire
Seer Enters into a Co-Marketing and Sales Agreement with Thermo Fisher Scientific - GlobeNewswire
PrognomiQ Raises $34M to Advance Multi-Omics Early Detection Test for Lung Cancer - HIT Consultant
PrognomiQ Announces $34 Million Series D Financing to Advance Development of Early Detection Test for Lung Cancer with Multi-omics Platform - The Manila Times
PrognomiQ Announces $34 Million Series D Financing to - GlobeNewswire
Earnings To Watch: Seer Inc (SEER) Reports Q3 2024 Result - GuruFocus.com
Organogenesis Holdings And 2 Other US Penny Stocks To Watch - Simply Wall St
Tarsus Pharmaceuticals (TARS) Surges 10.6%: Is This an Indication of Further Gains? - MSN
Seer Highlights Capability of Deep Proteomics to Enhance - GlobeNewswire
Seer Highlights Capability of Deep Proteomics to Enhance Genomic Insights Into Alzheimer’s, Lung Cancer, and More at ASHG 2024 - StockTitan
Seer (SEER) to Release Quarterly Earnings on Wednesday - MarketBeat
Seer Inc Stock (SEER) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.81%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):